Navidea Biopharmaceuticals Inc Денежные средства на акцию
Что обозначает Денежные средства на акцию в Navidea Biopharmaceuticals Inc?
Денежные средства на акцию Navidea Biopharmaceuticals Inc является 0.00
Какое определение для Денежные средства на акцию?
Денежные средства на акцию - это наличные денежные средства компании, поделенные на акции компании в обращении.
Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.
When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.
Денежные средства на акцию компаний в Health Care сектор на NYSEMKT по сравнению с Navidea Biopharmaceuticals Inc
Что делает Navidea Biopharmaceuticals Inc?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Компании с денежные средства на акцию похож на Navidea Biopharmaceuticals Inc
- BrainChip Ltd имеет Денежные средства на акцию из 0.00
- ACE Convergence Acquisition имеет Денежные средства на акцию из 0.00
- HeraMED имеет Денежные средства на акцию из 0.00
- Zenith Minerals имеет Денежные средства на акцию из 0.00
- Schrole Ltd имеет Денежные средства на акцию из 0.00
- Spey Resources Corp имеет Денежные средства на акцию из 0.00
- Navidea Biopharmaceuticals Inc имеет Денежные средства на акцию из 0.00
- Lefteris Acquisition имеет Денежные средства на акцию из 0.00
- Oge имеет Денежные средства на акцию из 0.00
- Laneway Resources имеет Денежные средства на акцию из 0.00
- Bermele plc имеет Денежные средства на акцию из 0.00
- Athena Resources имеет Денежные средства на акцию из 0.00
- Warrior Gold имеет Денежные средства на акцию из 0.00